These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 17118994)
1. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994 [TBL] [Abstract][Full Text] [Related]
3. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771 [TBL] [Abstract][Full Text] [Related]
4. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293 [TBL] [Abstract][Full Text] [Related]
5. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients. Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922 [TBL] [Abstract][Full Text] [Related]
8. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers. Milas M; Mazzaglia P; Chia SY; Skugor M; Berber E; Reddy S; Gupta M; Siperstein A Surgery; 2007 Feb; 141(2):137-46; discussion 146. PubMed ID: 17263967 [TBL] [Abstract][Full Text] [Related]
9. Circulating thyroid cancer markers. Gupta M; Chia SY Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468 [TBL] [Abstract][Full Text] [Related]
10. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A; Patel J; Brainard J; Gupta M; Nasr C; Hatipoglu B; Siperstein A; Berber E Surgery; 2016 Jan; 159(1):113-7. PubMed ID: 26454673 [TBL] [Abstract][Full Text] [Related]
13. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Lind P; Kohlfürst S Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610 [TBL] [Abstract][Full Text] [Related]
14. Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases. Janković Miljuš JR; Prosenc Zmrzljak U; Košir R; Jovanović M; Đorić IĐ; Rončević JV; Išić Denčić TM; Šelemetjev SA Ann Clin Biochem; 2024 Sep; 61(5):338-346. PubMed ID: 38195090 [TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. Batawil N; Alkordy T Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298 [TBL] [Abstract][Full Text] [Related]
16. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion. Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964 [TBL] [Abstract][Full Text] [Related]
17. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material. Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197 [TBL] [Abstract][Full Text] [Related]
18. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma. Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628 [TBL] [Abstract][Full Text] [Related]
19. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
20. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]